Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 6838 Supply Disruption — Zydus Pharmaceuticals (USA) I
Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 6838 Supply Disruption — Zydus Pharmaceuticals (USA) I is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 6838; Manufacturer: Zydus
| Drug name | Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 6838 |
|---|---|
| Manufacturer | Zydus Pharmaceuticals (USA) Inc |
| Recall/Disruption reason | Failed Dissolution Specifications |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0038-2024 |
| Initiation date | 20230921 |
| Quantity affected | 7,248 bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →